Evidence Hub

Validated RP-HPLC-UV Method for the Quantification of Trans-Resveratrol in Plasma: Application to Comprehensive Stability and Comparative Pharmacokinetic Studies

A. Marwa, Mahdi Jufri, W. K. Restu, Najihah Binti Mohd Hashim, A. Bahtiar

ACS Omega, 2026

2 citations

Abstract

Trans-resveratrol’s (trans-RES) therapeutic potential is limited by poor bioavailability and photolability. We developed and validated a robust RP-HPLC method, in accordance with the ICH M10 guideline, for the quantification of trans-RES in plasma. Excellent chromatographic separation of the trans- and cis-isomers was achieved using a liquid–liquid extraction procedure, followed by isocratic elution with a mobile phase consisting of 0.05% formic acid in water–acetonitrile (40:60, v/v). The method demonstrated high linearity (R 2 > 0.999) over the concentration range of 0.025 to 50 μg/mL. The method also demonstrated precision (%CV < 5%), accuracy (93.90–98.19%), and sensitivity (LLOQ 0.025 μg/mL). Stability studies confirmed trans-RES’s susceptibility to ultraviolet (UV)-induced isomerization, necessitating the implementation of photostability controls. The method’s environmental impact was evaluated using the Analytical GREEnness (AGREE) metric, yielding a favorable score of 0.7 that highlights its alignment with green chemistry principles. This fully validated protocol was successfully applied in the first comprehensive pharmacokinetic study comparing five administration routes in rats. Intraperitoneal administration yielded the highest bioavailability (84.92 ± 4.87%), significantly exceeding that of the oral route (4.91 ± 0.22%). Flip-flop kinetics observed for all nonintravenous routes indicated absorption-limited disposition. The validated method thus provides a…

Read the paper

Related studies

Go deeper in Evidence Hub

Evidence Hub adds a study data sheet (design, sample size, evidence level, key numbers), an AI summary and a chat grounded in the paper's text.

Open this study Sign up free